Public market insider selling at HEXO (HEXO)

Public market insider selling at HEXO (T:HEXO)

Terence Lake, a Senior Officer, disposed of 54,000 Common Shares on a direct ownership basis at a price of $10.490 on May 1st, 2019. This represents a $566,460 divestment of the company's shares and an account share holdings change of -85.9%.

William James Bursey, a Senior Officer, disposed of 25,000 Common Shares on a direct ownership basis at prices ranging from $10.581 to $10.633 on May 1st, 2019. This represents a $265,305 divestment of the company's shares and an account share holdings change of -100.0%.

Jason Ewart, a Director, disposed of 15,000 Common Shares on a direct ownership basis at prices ranging from $10.500 to $10.770 on May 1st, 2019. This represents a $158,850 divestment of the company's shares and an account share holdings change of -100.0%.

Devan Chandler Pennell, a Senior Officer, disposed of 5,000 Common Shares on a direct ownership basis at a price of $10.510 on May 1st, 2019. This represents a $52,550 divestment of the company's shares and an account share holdings change of -20.0%.

HEXO is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market. The Company operates with an approximately 300,000 square feet of production capacity. The Company serves the adult-use market under the HEXO brand, while it serves its medical cannabis clients through the Hydropothecary brand. The following are the Company's products under the Hydropothecary brand: Time of Day product line, which includes dried marijuana buds for morning, midday, after dinner and bedtime; Hydrogen (H2) classical medical marijuana line, which includes Papaya Grove, Green Chai and Kush dried marijuana buds, among others; Decarb ready to consume activated marijuana powder; Elixir cannabis oil sublingual spray, as well as Fleur de Lune intimate cannabis oil.